Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
Cholesterol-Lowering Drugs May Prevent Breast Cancer
Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
NCCN Updates Breast Cancer Guidelines for Patients
Lung Cancer Clinical Trials Cost-Effective Alternative
Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
New Drug Reduces Nausea and Vomiting
Clinical Trials Approved By NCI
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









